{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T00:16:22Z","timestamp":1703463382781},"reference-count":5,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_871_2022","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T11:31:26Z","timestamp":1683631886000},"page":"121-123","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Funding is associated with increased methodological and statistical reporting in onychomycosis randomised controlled\/comparative clinical trials"],"prefix":"10.25259","volume":"90","author":[{"given":"Julianne","family":"M. Falotico","sequence":"first","affiliation":[{"name":"Department of Dermatology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"D. Desai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"R. Lipner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Weill Cornell Medicine, New York, United States,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"10.25259\/IJDVL_871_2022\/ref-1","doi-asserted-by":"publisher","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLoS Med"},{"key":"10.25259\/IJDVL_871_2022\/ref-2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jaad.2021.12.022","article-title":"Reporting of primary outcome measures and sample size calculations in randomized controlled trials in dermatology journals","volume":"87","author":"Bridgman","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_871_2022\/ref-3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/09546634.2016.1161156","article-title":"How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives","volume":"27","author":"Gupta","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.25259\/IJDVL_871_2022\/ref-4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1046\/j.1365-4362.2003.01678.x","article-title":"Comparison of efficacy criteria across onychomycosis trials: Need for standardization","volume":"42","author":"Gupta","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.25259\/IJDVL_871_2022\/ref-5","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.jaad.2016.02.1242","article-title":"Response to \u201cA financial perspective on the topical treatment of onychomycosis\u201d","volume":"75","author":"Elewski","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/funding-is-associated-with-increased-methodological-and-statistical-reporting-in-onychomycosis-randomised-controlled-comparative-clinical-trials\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/funding-is-associated-with-increased-methodological-and-statistical-reporting-in-onychomycosis-randomised-controlled-comparative-clinical-trials\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T20:10:16Z","timestamp":1703448616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/funding-is-associated-with-increased-methodological-and-statistical-reporting-in-onychomycosis-randomised-controlled-comparative-clinical-trials\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":5,"alternative-id":["10.25259\/IJDVL_871_2022"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_871_2022","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"article-number":"121"}}